Collagen signature as a novel biomarker to predict axillary lymph node metastasis in breast cancer using multiphoton microscopy-Reference-Cited by-同舟云学术

Collagen signature as a novel biomarker to predict axillary lymph node metastasis in breast cancer using multiphoton microscopy

Published:2022-02-22 Issue:6 Volume:15 Page:
ISSN:1864-063X
Container-title:Journal of Biophotonics
language:en
Short-container-title:Journal of Biophotonics

Author:

Fang Ye¹,Kang Deyong²,Guo Wenhui³,Zhang Qingyuan⁴,Xu Shuoyu⁵,Huang Xingxin¹,Xi Gangqin¹,He Jiajia¹,Wu Shulian¹,Li Lianhuang¹,Han Xiahui¹,Chen Jianhua⁶,Zheng Liqin¹,Wang Chuan³,Chen Jianxin¹^ORCID

Affiliation:

1. Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology Fujian Normal University Fuzhou China

2. Department of Pathology Fujian Medical University Union Hospital Fuzhou China

3. Department of General Surgery Fujian Medical University Union Hospital Fuzhou China

4. Department of Medical Oncology Harbin Medical University Cancer Hospital Harbin China

5. Department of General Surgery, Nanfang Hospital Southern Medical University China

6. College of Life Sciences Fujian Normal University Fuzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,General Biochemistry, Genetics and Molecular Biology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbio.202100365

Reference40 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

3. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

4. Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis

5. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection